INSP - Inspire Medical Systems Inc Stock Price, Fair Value and News

159.75USD+1.16 (+0.73%)Market Closed

Market Summary

USD159.75+1.16

Market Closed

0.73%

INSP Alerts

1 major insider sales recently.

Big jump in Revenue (Y/Y)
Big jump in Earnings (Y/Y)
Losses in recent quarter

INSP Stock Price

View Fullscreen

INSP RSI Chart

INSP Valuation

Market Cap

4.7B

Price/Earnings (Trailing)

-301.66

Price/Sales (Trailing)

7.18

EV/EBITDA

-417.02

Price/Free Cashflow

1.4K

INSP Price/Sales (Trailing)

INSP Profitability

Operating Margin

97.94%

EBT Margin

-2.13%

Return on Equity

-2.67%

Return on Assets

-2.29%

Free Cashflow Yield

0.07%

INSP Fundamentals

INSP Revenue

Revenue (TTM)

660.9M

Rev. Growth (Yr)

28.24%

Rev. Growth (Qtr)

-14.8%

INSP Earnings

Earnings (TTM)

-15.7M

Earnings Growth (Yr)

35.13%

Earnings Growth (Qtr)

-167.77%

Breaking Down INSP Revenue

Last 7 days

-2.3%

Last 30 days

-28.5%

Last 90 days

-17.2%

Trailing 12 Months

-46.5%

How does INSP drawdown profile look like?

INSP Financial Health

Current Ratio

7.93

INSP Investor Care

Shares Dilution (1Y)

1.85%

Diluted EPS (TTM)

-0.53

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	660.9M	0	0	0
2023	466.4M	526.1M	570.2M	624.8M
2022	262.4M	300.9M	348.4M	407.9M
2021	134.4M	175.2M	201.0M	233.4M
2020	87.1M	81.3M	96.3M	115.4M
2019	56.8M	63.9M	71.7M	82.0M
2018	33.3M	38.2M	44.0M	50.6M
2017	19.5M	22.5M	25.5M	28.6M
2016	0	0	0	16.4M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Inspire Medical Systems Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 02, 2024	curet myriam	acquired	-	-	716	-
May 02, 2024	broader shelley g.	acquired	-	-	716	-
May 02, 2024	melenikiotou georgia	acquired	-	-	716	-
May 02, 2024	burks cynthia	acquired	-	-	716	-
May 02, 2024	mead dana g jr.	acquired	-	-	716	-
May 02, 2024	tansey casey m	acquired	-	-	716	-
May 02, 2024	ellis gary lee	acquired	-	-	716	-
May 02, 2024	mccormick shawn	acquired	-	-	716	-
Apr 29, 2024	nelson marilyn c	acquired	282,799	240	1,175	-

Which funds bought or sold INSP recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 15, 2024	AMUNDI	added	46.52	9,437,080	20,400,600	0.01%
May 15, 2024	SIRIOS CAPITAL MANAGEMENT L P	sold off	-100	-2,669,410	-	-%
May 15, 2024	D. E. Shaw & Co., Inc.	reduced	-82.97	-30,860,700	6,763,310	0.01%
May 15, 2024	OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	reduced	-4.71	10,473	1,736,580	0.12%
May 15, 2024	AQR CAPITAL MANAGEMENT LLC	added	44.63	6,801,850	19,708,100	0.03%
May 15, 2024	JANUS HENDERSON GROUP PLC	reduced	-0.01	158,797	2,925,920	-%
May 15, 2024	MILLENNIUM MANAGEMENT LLC	added	8.73	390,142	3,026,390	-%
May 15, 2024	Polar Asset Management Partners Inc.	sold off	-100	-8,096,510	-	-%
May 15, 2024	Tower Research Capital LLC (TRC)	added	390	570,146	706,444	0.02%
May 15, 2024	TWO SIGMA SECURITIES, LLC	new	-	1,001,140	1,001,140	0.01%

Are Funds Buying or Selling INSP?

Are funds buying INSP calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own INSP

No. of Funds

Unveiling Inspire Medical Systems Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	9.93%	2,931,469	SC 13G/A
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Jan 29, 2024	blackrock inc.	6.1%	1,800,118	SC 13G/A
Nov 13, 2023	fmr llc	-	0	SC 13G
Feb 09, 2023	fmr llc	-	0	SC 13G/A
Feb 09, 2023	vanguard group inc	10.31%	2,978,391	SC 13G/A
Jan 31, 2023	blackrock inc.	7.4%	2,135,708	SC 13G/A
Nov 10, 2022	vanguard group inc	10.04%	2,899,902	SC 13G/A
Feb 03, 2022	blackrock inc.	6.7%	1,846,227	SC 13G/A
Jan 10, 2022	fmr llc	-	0	SC 13G/A

Recent SEC filings of Inspire Medical Systems Inc

View All Filings

Date Filed	Form Type	Document
May 13, 2024	4	Insider Trading
May 07, 2024	10-Q	Quarterly Report
May 07, 2024	8-K	Current Report
May 07, 2024	8-K	Current Report
May 06, 2024	4	Insider Trading
May 06, 2024	4	Insider Trading
May 06, 2024	4	Insider Trading
May 06, 2024	4	Insider Trading
May 06, 2024	4	Insider Trading
May 06, 2024	4	Insider Trading

Peers (Alternatives to Inspire Medical Systems Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	181.9B	40.3B	-3.99%	-4.43%	32.33	4.51	-2.84%	-3.08%
BDX	68.5B	19.7B	1.04%	-5.28%	51.42	3.48	4.82%	-17.56%
ALGN	21.1B	3.9B	-8.05%	-4.13%	45.63	5.39	5.72%	46.72%
BAX	18.1B	14.9B	-11.51%	-17.62%	6.82	1.21	2.98%	207.68%
MID-CAP
ATR	9.8B	3.5B	6.53%	24.43%	31.2	2.75	6.16%	35.06%
HSIC	9.6B	12.5B	5.70%	-3.02%	24.67	0.77	-0.61%	-18.83%
BIO	8.6B	2.6B	0.13%	-21.80%	-26.61	3.29	-6.25%	-68.62%
XRAY	5.9B	3.9B	-8.58%	-30.13%	-62.71	1.49	0.23%	91.03%
AXNX	3.5B	387.1M	0.52%	27.70%	-216.75	8.92	30.82%	65.57%
PDCO	2.3B	6.6B	1.85%	-3.48%	11.96	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-0.51%	-11.36%	-1.88	0.4	7.94%	-1661.78%
ANIK	386.7M	169.3M	3.28%	2.59%	-5.03	2.28	7.49%	-244.90%
ANGO	254.7M	324.0M	0.79%	-32.56%	-1.32	0.79	-3.19%	-337.41%
APYX	48.8M	50.5M	2.90%	-74.91%	-2.14	0.97	14.25%	-10.06%
AEMD	1.0M	3.7M	-72.41%	25.00%	-0.09	0.28	5.77%	8.23%

Inspire Medical Systems Inc News

Latest updates

Inspire Medical Systems Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-14.8%	164,010,000	192,508,000	153,302,000	151,092,000	127,897,000	137,900,000	109,188,000	91,386,000	69,382,000	78,398,000	61,685,000	52,959,000	40,352,000	46,009,000	35,842,000	12,183,000	21,347,000	26,906,000	20,862,000	18,032,000	16,250,000
Gross Profit	-15.3%	139,253,000	164,454,000	128,920,000	126,840,000	108,009,000	115,748,000	89,402,000	77,213,000	59,378,000	67,242,000	53,061,000	45,441,000	34,371,000	38,848,000	30,631,000	10,229,000	18,050,000	22,667,000	17,406,000	14,938,000	13,396,000
Operating Expenses	-0.4%	154,471,000	155,157,000	142,391,000	143,439,000	127,507,000	116,083,000	106,596,000	91,220,000	75,434,000	69,063,000	62,857,000	57,985,000	50,060,000	45,910,000	40,523,000	33,043,000	34,490,000	31,960,000	26,057,000	23,114,000	22,173,000
S&GA Expenses	-100.0%	-	124,105,000	113,247,000	112,618,000	101,988,000	94,835,000	85,603,000	76,686,000	63,564,000	58,769,000	53,243,000	48,697,000	41,906,000	38,625,000	33,216,000	26,981,000	29,052,000	28,193,000	22,434,000	20,268,000	19,570,000
R&D Expenses	-7.1%	28,850,000	31,052,000	29,144,000	30,821,000	25,519,000	21,248,000	20,993,000	14,534,000	11,870,000	10,294,000	9,614,000	9,288,000	8,154,000	7,285,000	7,307,000	6,062,000	5,438,000	3,767,000	3,623,000	2,846,000	2,603,000
EBITDA Margin	39.3%	-0.02	-0.03	-0.05	-0.07	-0.08	-0.10	-0.13	-0.13	-0.15	-0.17	-0.22	-0.25	-	-	-	-	-	-	-	-	-
Interest Expenses	-	-	-	-	-	-	-	656,000	494,000	527,000	538,000	537,000	530,000	523,000	533,000	533,000	526,000	525,000	530,000	529,000	523,000	537,000
Income Taxes	28.7%	650,000	505,000	300,000	214,000	200,000	146,000	246,000	100,000	100,000	31,500	3,000	26,000	-	28,000	87,000	-	-	40,000	-	-	-
Earnings Before Taxes	-161.4%	-9,355,000	15,240,000	-8,200,000	-11,738,000	-15,208,000	3,275,000	-16,601,000	-14,348,000	-16,594,000	-2,371,000	-10,344,000	-13,062,000	-16,193,000	-7,456,000	-10,298,000	-23,089,000	-16,245,000	-9,040,000	-8,247,000	-7,650,000	-8,266,000
EBT Margin	33.3%	-0.02	-0.03	-0.06	-0.08	-0.09	-0.11	-0.14	-0.15	-0.16	-0.18	-0.23	-0.27	-	-	-	-	-	-	-	-	-
Net Income	-167.8%	-10,005,000	14,763,000	-8,540,000	-11,952,000	-15,424,000	3,150,000	-16,847,000	-14,490,000	-16,694,000	-2,391,000	-10,347,000	-13,088,000	-16,216,000	-7,484,000	-10,385,000	-23,089,000	-16,245,000	-9,080,000	-8,247,000	-7,650,000	-8,266,000
Net Income Margin	29.7%	-0.02	-0.03	-0.06	-0.08	-0.09	-0.11	-0.14	-0.15	-0.16	-0.18	-0.23	-0.27	-	-	-	-	-	-	-	-	-
Free Cashflow	-130.7%	-2,836,000	9,234,000	-3,350,000	237,000	-5,097,000	16,319,000	7,490,000	-7,373,000	-13,963,000	201,000	-1,489,000	-11,777,000	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	1.3%	686	677	639	618	572	565	528	292	290	295	279	272	273	281	272	271	166	181	183	186	190
Current Assets	-3.6%	572	594	570	560	534	530	496	263	262	269	255	249	261	270	267	267	155	171	170	177	189
Cash Equivalents	-5.5%	175	186	330	467	442	442	418	187	203	214	210	177	182	191	179	211	76.00	23.00	48.00	51.00	102
Inventory	44.5%	49.00	34.00	26.00	21.00	16.00	12.00	15.00	22.00	22.00	17.00	16.00	13.00	11.00	8.00	9.00	10.00	7.00	6.00	5.00	4.00	3.00
Net PPE	30.8%	52.00	40.00	32.00	25.00	21.00	17.00	14.00	11.00	9.00	8.00	8.00	7.00	7.00	5.00	4.00	3.00	3.00	3.00	3.00	2.00	1.00
Liabilities	-7.2%	97.00	104	95.00	89.00	67.00	69.00	57.00	65.00	65.00	66.00	59.00	52.00	50.00	51.00	43.00	38.00	38.00	41.00	37.00	33.00	32.00
Current Liabilities	-7.6%	72.00	78.00	70.00	67.00	60.00	61.00	49.00	47.00	43.00	41.00	34.00	24.00	19.00	21.00	18.00	13.00	14.00	17.00	13.00	9.00	8.00
Shareholder's Equity	2.9%	589	573	544	529	505	496	470	227	225	229	220	220	223	230	229	234	127	140	146	152	157
Retained Earnings	-2.9%	-355	-345	-360	-351	-339	-324	-327	-310	-296	-279	-277	-266	-253	-237	-229	-219	-196	-180	-171	-162	-155
Additional Paid-In Capital	3.0%	944	917	904	881	844	820	798	538	521	508	497	487	477	467	459	453	323	320	317	315	313
Accumulated Depreciation	11.5%	8.00	7.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.00	1.00	1.00
Shares Outstanding	0.4%	30.00	30.00	29.00	29.00	29.00	29.00	28.00	28.00	28.00	27.00	27.00	27.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	9,352	-	-	-	4,966	-	-	-	5,161	-	-	-	2,229	-	-	-	1,071	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-48.7%	8,860	17,267	3,638	5,092	-1,344	19,269	11,002	-5,954	-12,748	734	-338	-10,114	-10,401	-4,110	-8,909	-25,251	-14,775	-6,076	-2,944	-12,884	-10,942
Share Based Compensation	15.2%	26,322	22,849	19,829	21,567	18,225	15,001	14,589	12,659	9,721	7,030	6,810	6,341	5,997	3,854	3,311	2,903	2,749	1,893	1,524	1,389	1,391
Cashflow From Investing	87.1%	-19,535	-151,723	-144,241	4,895	-3,753	-2,950	-3,762	-11,419	-1,465	-533	30,149	844	-1,321	11,396	-25,929	33,919	67,241	-19,992	-501	-39,022	15,956
Cashflow From Financing	107.6%	768	-10,115	3,500	14,934	5,631	7,289	224,125	619	3,044	4,076	3,843	3,479	3,550	4,521	2,312	126,445	787	897	192	1,241	-366

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

INSP Income Statement

2024-03-31

Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenue	$ 164,010	$ 127,897
Cost of goods sold	24,757	19,888
Gross profit	139,253	108,009
Operating expenses:
Research and development	28,850	25,519
Selling, general and administrative	125,621	101,988
Total operating expenses	154,471	127,507
Operating loss	(15,218)	(19,498)
Other (income) expense:
Interest and dividend income	(5,923)	(4,273)
Other expense (income), net	60	(17)
Total other income	(5,863)	(4,290)
Loss before income taxes	(9,355)	(15,208)
Income taxes	650	216
Net loss	(10,005)	(15,424)
Other comprehensive loss:
Foreign currency translation (loss) gain	(134)	105
Unrealized (loss) gain on investments	(542)	13
Total comprehensive loss	$ (10,681)	$ (15,306)
Net loss per share, basic (in dollars per share)	$ (0.34)	$ (0.53)
Net loss per share, diluted (in dollars per share)	$ (0.34)	$ (0.53)
Weighted average common shares used to compute net loss per share, basic (in shares)	29,615,166	29,089,950
Weighted average common shares used to compute net loss per share, diluted (in shares)	29,615,166	29,089,950

INSP Balance Sheet

2024-03-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 175,416	$ 185,537
Investments, short-term	265,945	274,838
Accounts receivable, net of allowance for credit losses of $256 and $1,648, respectively	72,333	89,884
Inventories, net	48,974	33,885
Prepaid expenses and other current assets	9,546	9,595
Total current assets	572,214	593,739
Investments, long-term	27,803	9,143
Property and equipment, net	52,281	39,984
Operating lease right-of-use assets	22,248	22,667
Other non-current assets	11,296	11,278
Total assets	685,842	676,811
Current liabilities:
Accounts payable	43,802	38,839
Accrued expenses	28,370	39,266
Total current liabilities	72,172	78,105
Operating lease liabilities, non-current portion	24,500	24,846
Other non-current liabilities	146	1,346
Total liabilities	96,818	104,297
Stockholders' equity:
Preferred Stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding	0	0
Common Stock, $0.001 par value per share; 200,000,000 shares authorized; 29,676,095 and 29,560,464 issued and outstanding at March 31, 2024 and December 31, 2023, respectively	30	30
Additional paid-in capital	944,298	917,107
Accumulated other comprehensive income	124	800
Accumulated deficit	(355,428)	(345,423)
Total stockholders' equity	589,024	572,514
Total liabilities and stockholders' equity	$ 685,842	$ 676,811

About Inspire Medical Systems Inc

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

CEO	Mr. Timothy P. Herbert
WEBSITE	inspiresleep.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	755

Inspire Medical Systems Inc Frequently Asked Questions

What is the ticker symbol for Inspire Medical Systems Inc? What does INSP stand for in stocks?

INSP is the stock ticker symbol of Inspire Medical Systems Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Inspire Medical Systems Inc (INSP)?

As of Wed May 15 2024, market cap of Inspire Medical Systems Inc is 4.74 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of INSP stock?

You can check INSP's fair value in chart for subscribers.

What is the fair value of INSP stock?

You can check INSP's fair value in chart for subscribers. The fair value of Inspire Medical Systems Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Inspire Medical Systems Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for INSP so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Inspire Medical Systems Inc a good stock to buy?

The fair value guage provides a quick view whether INSP is over valued or under valued. Whether Inspire Medical Systems Inc is cheap or expensive depends on the assumptions which impact Inspire Medical Systems Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for INSP.

What is Inspire Medical Systems Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed May 15 2024, INSP's PE ratio (Price to Earnings) is -301.43 and Price to Sales (PS) ratio is 7.18. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. INSP PE ratio will change depending on the future growth rate expectations of investors.